生物駭客市場機會、成長動力、產業趨勢分析及 2025 - 2034 年預測

2024 年全球生物駭客市場價值為 245 億美元，預計到 2034 年將以 16.5% 的複合年成長率成長，達到 1,113 億美元。生物駭客正在成為科學、技術和自我提升交叉領域的變革趨勢。它為個人提供透過個人化介入來控制其身心健康的工具。從營養和睡眠最佳化到基因工程和植入式設備，生物駭客的範圍很廣且不斷發展。推動這項運動的因素是消費者日益轉向預防性醫療保健和性能最佳化。

人們不再等待症狀出現，而是使用即時資料和先進的健康工具來預防問題並改善生活品質。隨著醫療保健變得越來越個人化，對創新解決方案的需求也在不斷成長，這些解決方案允許使用者以自己的方式監測、分析和微調他們的生物功能。慢性病的增多、醫療成本的上漲以及可負擔的穿戴式技術的普及，正在加速全球生物駭客實踐的採用。社群媒體、線上健康社群和鼓勵實驗和知識共享的 DIY 生物學團體進一步放大了這一趨勢。

穿戴式科技領域在 2024 年創造了 70 億美元的產值，預計到 2034 年將以 16.8% 的複合年成長率成長。越來越多的用戶開始使用智慧手錶、健身手環和智慧戒指來追蹤睡眠週期、心率、大腦活動和日常表現水平等重要指標。這些設備即時提供個人化見解，幫助用戶識別趨勢、做出明智的決定並調整日常生活以獲得更好的健康結果。透過提供持續的追蹤和可操作的回饋，穿戴式科技正在成為個人尋求提升健康和保健之旅的重要工具。檢測生理或認知狀態的早期變化的能力使用戶能夠儘早干預、調整習慣並預防潛在的健康問題。

在應用方面，診斷和治療領域在 2024 年創造了 70 億美元的收入，佔了 28.4% 的市場佔有率。糖尿病和心血管疾病等慢性病在全球的負擔日益加重，促使使用者尋求對自身健康的更多控制。透過先進的感測器和家庭監測工具，生物駭客可以追蹤血糖水平、荷爾蒙波動、血壓等。這種即時資料存取支援早期檢測，鼓勵預防性護理，並減少對傳統醫療保健訪問的依賴。它使用戶能夠根據精確的健康資料改變行為和生活方式，從而顯著降低長期健康風險。

2023 年，美國生物駭客市場產值達 79 億美元。該國慢性病發病率高，持續推動先進生物駭客工具的需求。來自醫療機構、生物技術公司和新創企業的尖端研究推動了整個領域的創新。公司越來越關注疾病預防、個人化健康解決方案和下一代技術開發。

全球生物駭客產業的一些知名參與者包括 Neuralink、Oura Health Oy、WHOOP、Cyborg Nest、Muse、Cronometer、OpenBCI、Senseonics、Synbiota、Thync Global、Viome Life Science、Fitbit、TrackMyStack、Nuanic、OsteoStrong 和 Proteus Digital Health。為了保持競爭力，這些公司大力投資研發，推出下一代穿戴式設備，擴大產品線，並整合人工智慧驅動的健康平台。在這個快速成長的領域，策略合作夥伴關係、市場擴張和數位創新仍然是吸引消費者和提升品牌價值的關鍵。

目錄

第1章：方法論與範圍

第2章：執行摘要

第3章：行業洞察

• 產業生態系統分析
• 產業衝擊力
  • 成長動力
    • 慢性病盛行率上升
    • 生物駭客技術進步
    • 穿戴式裝置需求不斷成長
    • 提高健康意識
  • 產業陷阱與挑戰
    • 先進設備成本高昂
    • 缺乏熟練的專業人員
• 成長潛力分析
• 監管格局
• 技術格局
• 未來市場趨勢
• 波特的分析
• PESTEL分析

第4章：競爭格局

• 介紹
• 公司市佔率分析
• 公司矩陣分析
• 主要市場參與者的競爭分析
• 競爭定位矩陣
• 策略儀表板

第5章：市場估計與預測：按產品，2021 - 2034 年

• 主要趨勢
• 穿戴
  • 穿戴式神經技術
  • 大浦環
  • 繆斯頭帶
  • 其他穿戴式裝置
• 植入物
  • 血液檢測植入物
  • Circadia植入物
  • 心臟和血管植入物
  • 其他植入物
• 基因改造試劑盒
• 聰明藥
• 補充品
• 行動應用程式
• 其他產品

第6章：市場估計與預測：按應用，2021 - 2034 年

• 主要趨勢
• 合成生物學
• 基因工程
• 法醫學
• 診斷和治療
• 藥物檢測
• 其他應用

第7章：市場估計與預測：依最終用途，2021 - 2034 年

• 主要趨勢
• 醫院和診所
• 製藥和生物技術公司
• 法醫實驗室
• 學術和研究機構

第8章：市場估計與預測：按地區，2021 - 2034 年

• 主要趨勢
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 英國
  • 法國
  • 西班牙
  • 義大利
  • 荷蘭
• 亞太地區
  • 中國
  • 日本
  • 印度
  • 澳洲
  • 韓國
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
• 中東和非洲
  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國

第9章：公司簡介

• Cyborg Nest
• Cronometer
• Fitbit
• Muse
• Nuanic
• Neuralink
• OpenBCI
• OsteoStrong
• Oura Health Oy
• Proteus Digital Health
• TrackMyStack
• Thync Global
• Synbiota
• Senseonics
• Viome Life Science
• WHOOP

The Global Biohacking Market was valued at USD 24.5 billion in 2024 and is estimated to grow at a CAGR of 16.5% to reach USD 111.3 billion by 2034. Biohacking is emerging as a transformative trend at the intersection of science, technology, and self-improvement. It offers individuals the tools to take control of their physical and mental well-being through personalized interventions. From nutrition and sleep optimization to genetic engineering and implantable devices, the spectrum of biohacking is broad and constantly evolving. What's fueling this movement is the growing consumer shift toward preventive healthcare and performance optimization.

People are no longer waiting for symptoms to act-they're using real-time data and advanced health tools to preempt issues and enhance quality of life. As healthcare becomes more individualized, demand is rising for innovative solutions that allow users to monitor, analyze, and fine-tune their biological functions on their own terms. The rise in chronic illnesses, increasing healthcare costs, and growing access to affordable wearable tech are accelerating the adoption of biohacking practices worldwide. This trend is further amplified by social media, online health communities, and DIY biology groups that encourage experimentation and knowledge sharing.

The wearable technology segment generated USD 7 billion in 2024 and is projected to grow at a CAGR of 16.8% through 2034. Users are increasingly turning to smartwatches, fitness bands, and smart rings to track vital metrics like sleep cycles, heart rate, brain activity, and daily performance levels. These devices offer personalized insights in real-time, helping users identify trends, make informed decisions, and tweak their daily routines for better health outcomes. By providing continuous tracking and actionable feedback, wearable tech is becoming an essential tool for individuals looking to upgrade their health and wellness journeys. The ability to detect early changes in physiological or cognitive states gives users the power to intervene early, adjust habits, and stay ahead of potential health concerns.

In terms of application, the diagnosis and treatment segment generated USD 7 billion and held a 28.4% market share in 2024. The growing global burden of chronic conditions like diabetes and cardiovascular disease is pushing users to seek more control over their health. Through advanced sensors and home-based monitoring tools, biohackers can track glucose levels, hormone fluctuations, blood pressure, and more. This real-time data access supports early detection, encourages preventative care, and reduces dependency on traditional healthcare visits. It empowers users to make behavior and lifestyle changes based on precise health data, significantly lowering long-term health risks.

The United States Biohacking Market generated USD 7.9 billion in 2023. The country's high incidence of chronic conditions continues to drive demand for advanced biohacking tools. Cutting-edge research from healthcare institutions, biotech firms, and startups fuels innovation across the space. Companies are increasingly focused on disease prevention, personalized health solutions, and next-gen technology development.

Some of the prominent players in the Global Biohacking Industry include Neuralink, Oura Health Oy, WHOOP, Cyborg Nest, Muse, Cronometer, OpenBCI, Senseonics, Synbiota, Thync Global, Viome Life Science, Fitbit, TrackMyStack, Nuanic, OsteoStrong, and Proteus Digital Health. To stay competitive, these companies are heavily investing in research and development, launching next-gen wearable devices, expanding their product lines, and integrating AI-driven health platforms. Strategic partnerships, market expansion, and digital innovation remain key to engaging consumers and elevating brand value in this fast-growing space.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rising prevalence of chronic diseases
    • 3.2.1.2 Technological advancements in biohacking
    • 3.2.1.3 Growing demand for wearable devices
    • 3.2.1.4 Increasing health awareness
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High costs of advanced devices
    • 3.2.2.2 Lack of skilled professionals
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Technological landscape
• 3.6 Future market trends
• 3.7 Porter’s analysis
• 3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2034 ($ Mn)

• 5.1 Key trends
• 5.2 Wearable
  • 5.2.1 Wearable neurotech
  • 5.2.2 Oura ring
  • 5.2.3 Muse headband
  • 5.2.4 Other wearables
• 5.3 Implants
  • 5.3.1 Blood test implant
  • 5.3.2 Circadia implant
  • 5.3.3 Cardiac and vascular implants
  • 5.3.4 Other implants
• 5.4 Gene modification kits
• 5.5 Smart drugs
• 5.6 Supplements
• 5.7 Mobile apps
• 5.8 Other products

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2034 ($ Mn)

• 6.1 Key trends
• 6.2 Synthetic biology
• 6.3 Genetic engineering
• 6.4 Forensic science
• 6.5 Diagnosis and treatment
• 6.6 Drug testing
• 6.7 Other applications

Chapter 7 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

• 7.1 Key trends
• 7.2 Hospitals and clinics
• 7.3 Pharmaceutical and biotechnology companies
• 7.4 Forensic laboratories
• 7.5 Academic and research institutes

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Netherlands
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
• 8.6 Middle East and Africa
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 UAE

Chapter 9 Company Profiles

• 9.1 Cyborg Nest
• 9.2 Cronometer
• 9.3 Fitbit
• 9.4 Muse
• 9.5 Nuanic
• 9.6 Neuralink
• 9.7 OpenBCI
• 9.8 OsteoStrong
• 9.9 Oura Health Oy
• 9.10 Proteus Digital Health
• 9.11 TrackMyStack
• 9.12 Thync Global
• 9.13 Synbiota
• 9.14 Senseonics
• 9.15 Viome Life Science
• 9.16 WHOOP